The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Alternatives to Conventional Antibiotics in the Era of Antimicrobial Resistance
Abstract
As more antibiotics are rendered ineffective by drug-resistant bacteria, focus must be shifted towards alternative therapies for treating infections. Although several alternatives already exist in nature, the challenge is to implement them in clinical use. Advancements within biotechnology, genetic engineering, and synthetic chemistry have opened up new avenues towards the search for therapies that can substitute for antibiotics. This review provides an introduction to the various promising approaches that have been adopted in this regard. Whilst the use of bacteriophages and antibodies has been partly implemented, other promising strategies, such as probiotics, lysins, and antimicrobial peptides, are in various stages of development. Propitious concepts such as genetically modified phages, antibacterial oligonucleotides, and CRISPR-Cas9 are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Hancock, R. E. W., & Sahl, H.-G. (2006) · Nature Biotechnology · doi:10.1038/nbt1267 · Cited by 4,208
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153 · cited 1×
“CRISPR-Cas 9 Ever since its discovery, the CRISPR (clustered, regularly interspaced, short palindromic repeats)-Cas9 (CRISP-associated protein 9) system has taken the world by storm [114,115].”
BackgroundPeptide therapeutics: current status and future directions
Fosgerau, K., & Hoffmann, T. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.003 · Cited by 3,030
Bacteriophage resistance mechanisms
Labrie, S. J., Samson, J. E., & Moineau, S. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2315 · Cited by 2,397
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
Mahlapuu, M., Håkansson, J., Ringstad, L., & Björn, C. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00194 · Cited by 1,927
Bacteriocins—A viable alternative to antibiotics?
Cotter, P. D., Ross, R. P., & Hill, C. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2937 · Cited by 1,793
CRISPR/Cas9 in Genome Editing and Beyond
Wang, H., La Russa, M., & Qi, L. S. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014607 · Cited by 1,110
Zhang, L.-J., & Gallo, R. L. (2016) · Current Biology · doi:10.1016/j.cub.2015.11.017 · Cited by 1,029
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials
Bikard, D., Euler, C. W., Jiang, W., Nussenzweig, P. M., Goldberg, G. W., Duportet, X., Fischetti, V. A., & Marraffini, L. A. (2014) · Nature Biotechnology · doi:10.1038/nbt.3043 · Cited by 986
Phage treatment of human infections
Abedon, S. T., Kuhl, S. J., Blasdel, B. G., & Kutter, E. M. (2011) · Bacteriophage · doi:10.4161/bact.1.2.15845 · Cited by 980
The immunology of host defence peptides: beyond antimicrobial activity
Hancock, R. E. W., Haney, E. F., & Gill, E. E. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.29 · Cited by 945
Dispersing biofilms with engineered enzymatic bacteriophage
Lu, T. K., & Collins, J. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704624104 · Cited by 895
Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases
Citorik, R. J., Mimee, M., & Lu, T. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.3011 · Cited by 808
Bacteriophage Endolysins as Novel Antimicrobials
Schmelcher, M., Donovan, D. M., & Loessner, M. J. (2012) · Future Microbiology · doi:10.2217/fmb.12.97 · Cited by 785
Antibacterial activities of bacteriocins: application in foods and pharmaceuticals
Yang, S.-C., Lin, C.-H., Sung, C. T., & Fang, J.-Y. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00241 · Cited by 726
Mechanisms and consequences of bacterial resistance to antimicrobial peptides
Andersson, D. I., Hughes, D., & Kubicek-Sutherland, J. Z. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.04.002 · Cited by 715
Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa
Chan, B. K., Sistrom, M., Wertz, J. E., Kortright, K. E., Narayan, D., & Turner, P. E. (2016) · Scientific Reports · doi:10.1038/srep26717 · Cited by 715
Phage Therapy in Clinical Practice: Treatment of Human Infections
Kutter, E., De Vos, D., Gvasalia, G., Alavidze, Z., Gogokhia, L., Kuhl, S., & Abedon, S. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725401 · Cited by 670
Intracellular Targeting Mechanisms by Antimicrobial Peptides
Le, C.-F., Fang, C.-M., & Sekaran, S. D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02340-16 · Cited by 603
Immune modulation by multifaceted cationic host defense (antimicrobial) peptides
Hilchie, A. L., Wuerth, K., & Hancock, R. E. W. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1393 · Cited by 601
Antimicrobial Polymeric Materials with Quaternary Ammonium and Phosphonium Salts
Xue, Y., Xiao, H., & Zhang, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16023626 · Cited by 578
Tew, G. N., Scott, R. W., Klein, M. L., & DeGrado, W. F. (2010) · Accounts of Chemical Research · doi:10.1021/ar900036b · Cited by 552
Guilhelmelli, F., Vilela, N., Albuquerque, P., Derengowski, L. D. S., Silva-Pereira, I., & Kyaw, C. M. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00353 · Cited by 546
Modulating immunity as a therapy for bacterial infections
Hancock, R. E. W., Nijnik, A., & Philpott, D. J. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2745 · Cited by 535
Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy
Lu, T. K., & Collins, J. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800442106 · Cited by 529
Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria
Yosef, I., Manor, M., Kiro, R., & Qimron, U. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500107112 · Cited by 483
Gut microbiota: a potential new territory for drug targeting
Jia, W., Li, H., Zhao, L., & Nicholson, J. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2505 · Cited by 475
Genetically Engineered Phages: a Review of Advances over the Last Decade
Pires, D. P., Cleto, S., Sillankorva, S., Azeredo, J., & Lu, T. K. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00069-15 · Cited by 427
Castagliuolo, I., Riegler, M. F., Valenick, L., LaMont, J. T., & Pothoulakis, C. (1999) · Infection and Immunity · doi:10.1128/iai.67.1.302-307.1999 · Cited by 408
Rea, M. C., Dobson, A., O'Sullivan, O., Crispie, F., Fouhy, F., Cotter, P. D., Shanahan, F., Kiely, B., Hill, C., & Ross, R. P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001224107 · Cited by 377
Common mechanisms of target cell recognition and immunity for class II bacteriocins
Diep, D. B., Skaugen, M., Salehian, Z., Holo, H., & Nes, I. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608775104 · Cited by 374
Nelson, D. C., Schmelcher, M., Rodriguez-Rubio, L., Klumpp, J., Pritchard, D. G., Dong, S., & Donovan, D. M. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00007-4 · Cited by 372
Probiotics: a role in the treatment of intestinal infection and inflammation?
Isolauri, E., Kirjavainen, P. V., & Salminen, S. (2002) · Gut · doi:10.1136/gut.50.suppl_3.iii54 · Cited by 367
Emerging trends in macromolecular antimicrobials to fight multi-drug-resistant infections
Engler, A. C., Wiradharma, N., Ong, Z. Y., Coady, D. J., Hedrick, J. L., & Yang, Y.-Y. (2012) · Nano Today · doi:10.1016/j.nantod.2012.04.003 · Cited by 357
De Novo Design of Antibacterial β-Peptides
Hamuro, Y., Schneider, J. P., & DeGrado, W. F. (1999) · Journal of the American Chemical Society · doi:10.1021/ja992728p · Cited by 345
Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials
Clark, J. R., & March, J. B. (2006) · Trends in Biotechnology · doi:10.1016/j.tibtech.2006.03.003 · Cited by 343
De Novo Design, Synthesis, and Characterization of Antimicrobial β-Peptides
Liu, D., & DeGrado, W. F. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0107475 · Cited by 339
Bacteriophage Endolysins as a Novel Class of Antibacterial Agents
Borysowski, J., Weber-Dąbrowska, B., & Górski, A. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100402 · Cited by 338
Anionic Antimicrobial Peptides from Eukaryotic Organisms
Harris, F., Dennison, S., & Phoenix, D. (2009) · Current Protein & Peptide Science · doi:10.2174/138920309789630589 · Cited by 332
De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers
Choi, S., Isaacs, A., Clements, D., Liu, D., Kim, H., Scott, R. W., Winkler, J. D., & DeGrado, W. F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811818106 · Cited by 308
Isolauri, E. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.6.1142s · Cited by 291
Recent Progress in Polymer Research to Tackle Infections and Antimicrobial Resistance
Konai, M. M., Bhattacharjee, B., Ghosh, S., & Haldar, J. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00458 · Cited by 281
Self-citationRecent Advances in Antimicrobial Polymers: A Mini-Review
Huang, K.-S., Yang, C.-H., Huang, S.-L., Chen, C.-Y., Lu, Y.-Y., & Lin, Y.-S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091578 · Cited by 279
The role of probiotics in the treatment and prevention of Helicobacter pylori infection
Hamilton-Miller, J. M. T. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00153-5 · Cited by 222
Reversing Bacterial Resistance to Antibiotics by Phage-Mediated Delivery of Dominant Sensitive Genes
Edgar, R., Friedman, N., Molshanski-Mor, S., & Qimron, U. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.05741-11 · Cited by 217
Ceragenins: Cholic Acid-Based Mimics of Antimicrobial Peptides
Lai, X.-Z., Feng, Y., Pollard, J., Chin, J. N., Rybak, M. J., Bucki, R., Epand, R. F., Epand, R. M., & Savage, P. B. (2008) · Accounts of Chemical Research · doi:10.1021/ar700270t · Cited by 214
Antimicrobial Peptides Under Clinical Trials
E. Greber, K., & Dawgul, M. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160713143331 · Cited by 210
Mansour, S. C., de la Fuente‐Núñez, C., & Hancock, R. E. W. (2015) · Journal of Peptide Science · doi:10.1002/psc.2708 · Cited by 208
Small Molecular Antibacterial Peptoid Mimics: The Simpler the Better!
Ghosh, C., Manjunath, G. B., Akkapeddi, P., Yarlagadda, V., Hoque, J., Uppu, D. S. S. M., Konai, M. M., & Haldar, J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401680a · Cited by 205
Self-citationPredatory Bacteria: A Potential Ally against Multidrug-Resistant Gram-Negative Pathogens
Kadouri, D. E., To, K., Shanks, R. M. Q., & Doi, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063397 · Cited by 186
Bdellovibrio as therapeutic agents: a predatory renaissance?
Sockett, R. E., & Lambert, C. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro959 · Cited by 185
Comparative Mechanistic Studies of Brilacidin, Daptomycin, and the Antimicrobial Peptide LL16
Mensa, B., Howell, G. L., Scott, R., & DeGrado, W. F. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02955-14 · Cited by 185
Atterbury, R. J., Hobley, L., Till, R., Lambert, C., Capeness, M. J., Lerner, T. R., Fenton, A. K., Barrow, P., & Sockett, R. E. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.00426-11 · Cited by 178
Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics
Rodríguez-Rubio, L., Martínez, B., Donovan, D. M., Rodríguez, A., & García, P. (2013) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2012.723675 · Cited by 173
Monoclonal antibody-based therapies for microbial diseases
Saylor, C., Dadachova, E., & Casadevall, A. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.09.105 · Cited by 172
A Synthetic Antimicrobial Peptidomimetic (LTX 109): Stereochemical Impact on Membrane Disruption
Isaksson, J., Brandsdal, B. O., Engqvist, M., Flaten, G. E., Svendsen, J. S. M., & Stensen, W. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200450h · Cited by 169
Challenges and future prospects of antibiotic therapy: from peptides to phages utilization
Mandal, S. M., Roy, A., Ghosh, A. K., Hazra, T. K., Basak, A., & Franco, O. L. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00105 · Cited by 159
Membrane‐Active Small Molecules: Designs Inspired by Antimicrobial Peptides
Ghosh, C., & Haldar, J. (2015) · ChemMedChem · doi:10.1002/cmdc.201500299 · Cited by 159
Self-citationUsing CRISPR-Cas systems as antimicrobials
Bikard, D., & Barrangou, R. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.08.005 · Cited by 156
Synthetic Random Copolymers as a Molecular Platform To Mimic Host-Defense Antimicrobial Peptides
Takahashi, H., Caputo, G. A., Vemparala, S., & Kuroda, K. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00114 · Cited by 143
Bacteriophage therapy: a regulatory perspective
Pelfrene, E., Willebrand, E., Sanches, A., Sebris, Z., & Cavaleri, M. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw083 · Cited by 133
Hoque, J., Konai, M. M., Sequeira, S. S., Samaddar, S., & Haldar, J. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01435 · Cited by 126
Self-citationKonai, M. M., Ghosh, C., Yarlagadda, V., Samaddar, S., & Haldar, J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5013566 · Cited by 124
Self-citationAntimicrobial β-Peptides and α-Peptoids
Godballe, T., Nilsson, L. L., Petersen, P. D., & Jenssen, H. (2010) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2010.01067.x · Cited by 123
Bechinger, B. (2014) · Journal of Peptide Science · doi:10.1002/psc.2729 · Cited by 123
The Escherichia coli Yej Transporter Is Required for the Uptake of Translation Inhibitor Microcin C
Новикова, М. А., Metlitskaya, A. Z., Datsenko, K. A., Kazakov, T., Kazakov, A. S., Wanner, B. L., & Severinov, K. (2007) · Journal of Bacteriology · doi:10.1128/jb.01028-07 · Cited by 118
Phage therapy of pulmonary infections
Abedon, S. T. (2015) · Bacteriophage · doi:10.1080/21597081.2015.1020260 · Cited by 117
Polymers with tunable side-chain amphiphilicity as non-hemolytic antibacterial agents
Uppu, D. S. S. M., Akkapeddi, P., Manjunath, G. B., Yarlagadda, V., Hoque, J., & Haldar, J. (2013) · Chemical Communications · doi:10.1039/c3cc43751e · Cited by 117
Self-citationEngineered Phagemids for Nonlytic, Targeted Antibacterial Therapies
Krom, R. J., Bhargava, P., Lobritz, M. A., & Collins, J. J. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b01943 · Cited by 108
Hoque, J., Konai, M. M., Gonuguntla, S., Manjunath, G. B., Samaddar, S., Yarlagadda, V., & Haldar, J. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00443 · Cited by 106
Self-citationNilsson, A. C., Janson, H., Wold, H., Fugelli, A., Andersson, K., Håkangård, C., Olsson, P., & Olsen, W. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03513-14 · Cited by 103
In Vivo, In Vitro, and In Silico Characterization of Peptoids as Antimicrobial Agents
Czyzewski, A. M., Jenssen, H., Fjell, C. D., Waldbrook, M., Chongsiriwatana, N. P., Yuen, E., Hancock, R. E. W., & Barron, A. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0135961 · Cited by 102
Antibodies for the treatment of bacterial infections: current experience and future prospects
Bebbington, C. R., & Yarranton, G. T. (2008) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2008.10.002 · Cited by 100
Influence of Saccharomyces boulardii CNCM I-745 on the gut-associated immune system
Stier, H., & Bischoff, S. C. (2016) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s111003 · Cited by 99
Achtman, A. H., Pilat, S., Law, C. W., Lynn, D. J., Janot, L., Mayer, M. L., Ma, S., Kindrachuk, J., Finlay, B. B., Brinkman, F. S. L., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003515 · Cited by 94
Uppu, D. S. S. M., Samaddar, S., Hoque, J., Konai, M. M., Krishnamoorthy, P., Shome, B. R., & Haldar, J. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.6b01057 · Cited by 92
Self-citationProbiotics for infectious diseases: more drugs, less dietary supplementation
Kotzampassi, K. E., & Giamarellos‐Bourboulis, E. J. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.06.006 · Cited by 91
Enfuvirtide: A fusion inhibitor for the treatment of HIV infection
Fung, H. B., & Guo, Y. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90032-x · Cited by 89
Konai, M. M., & Haldar, J. (2015) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00056 · Cited by 85
Self-citationUppu, D. S. S. M., Samaddar, S., Ghosh, C., Krishnamoorthy, P., Shome, B. R., & Haldar, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.09.042 · Cited by 84
Self-citationSequence-Specific Targeting of Bacterial Resistance Genes Increases Antibiotic Efficacy
Ayhan, D. H., Tamer, Y. T., Akbar, M. A., Bailey, S. M., Wong, M., Daly, S. M., Greenberg, D. E., & Toprak, E. (2016) · PLoS Biology · doi:10.1371/journal.pbio.1002552 · Cited by 82
Hoque, J., Konai, M. M., Samaddar, S., Gonuguntala, S., Manjunath, G. B., Ghosh, C., & Haldar, J. (2015) · Chemical Communications · doi:10.1039/c5cc05159b · Cited by 81
Self-citationMimics of Host Defense Proteins; Strategies for Translation to Therapeutic Applications
Scott, R. W., & Tew, G. N. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160713130452 · Cited by 80
Meng, J., Wang, H., Hou, Z., Chen, T., Fu, J., Ma, X., He, G., Xue, X., Jia, M., & Luo, X. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01542-08 · Cited by 76
de la Fuente‐Núñez, C., & Lu, T. K. (2016) · Integrative Biology · doi:10.1039/c6ib00140h · Cited by 76
The action of the bacterial toxin, microcin B17, on DNA gyrase
Parks, W. M., Bottrill, A. R., Pierrat, O. A., Durrant, M. C., & Maxwell, A. (2007) · Biochimie · doi:10.1016/j.biochi.2006.12.005 · Cited by 75
Kokai‐Kun, J. F., Roberts, T., Coughlin, O., Sicard, É., Rufiange, M., Fedorak, R. N., Carter, C., Adams, M. H., Longstreth, J. A., Whalen, H., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02197-16 · Cited by 73
Pseudomonas aeruginosa Pore-Forming Exolysin and Type IV Pili Cooperate To Induce Host Cell Lysis
Basso, P., Ragno, M., Elsen, S., Reboud, E., Golovkine, G. R., Bouillot, S., Huber, P., Lory, S. J., Faudry, É., & Attrée, I. (2017) · mBio · doi:10.1128/mbio.02250-16 · Cited by 72
Molecular Determinants of Microbial Resistance to Thiopeptide Antibiotics
Baumann, S., Schoof, S., Bolten, M., Haering, C., Takagi, M., Shin‐ya, K., & Arndt, H. (2010) · Journal of the American Chemical Society · doi:10.1021/ja909317n · Cited by 71
Inhibition of Pseudomonas aeruginosa by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers
Howard, J. J., Sturge, C. R., Moustafa, D. A., Daly, S. M., Marshall‐Batty, K. R., Felder-Scott, C. F., Zamora, D., Yabe-Gill, M., Labandeira‐Rey, M., Bailey, S. M., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01938-16 · Cited by 66
The Structure and Biological Aspects of Peptide Antibiotic Microcin J25
Vincent, P. A., & Morero, R. D. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787458461 · Cited by 64
Binaphthyl‐Based Dicationic Peptoids with Therapeutic Potential
Bremner, J. B., Keller, P. A., Pyne, S. G., Boyle, T. P., Brkić, Z., David, D. M., Garas, A. M. S., Morgan, J., Robertson, M. J., Somphol, K., et al. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200904392 · Cited by 62
Lipopolysaccharide Neutralization by Cationic-Amphiphilic Polymers through Pseudoaggregate Formation
Uppu, D. S. S. M., & Haldar, J. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.5b01567 · Cited by 60
Self-citationKonai, M. M., & Haldar, J. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00055 · Cited by 60
Self-citationKobayashi, Y., Ichioka, M., Hirose, T., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.08.037 · Cited by 59
Sensitization of Gram-negative bacteria to rifampin and OAK combinations
Jammal, J., Zaknoon, F., Kaneti, G., Goldberg, K., & Mor, A. (2015) · Scientific Reports · doi:10.1038/srep09216 · Cited by 55
Synthetic biology platform technologies for antimicrobial applications
Braff, D., Shis, D. L., & Collins, J. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.006 · Cited by 55
Sensitizing pathogens to antibiotics using the CRISPR-Cas system
Goren, M. G., Yosef, I., & Qimron, U. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.11.001 · Cited by 52
Microbiota-Based Therapies for Clostridium difficile and Antibiotic-Resistant Enteric Infections
Lewis, B. B., & Pamer, E. G. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090816-093549 · Cited by 50
(2014) · PubMed Central · Cited by 45
Teyssières, E., Corre, J., Antunes, S., Rougeot, C., Dugave, C., Jouvion, G., Claudon, P., Mikaty, G., Douat, C., Goossens, P. L., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00144 · Cited by 45
Ghosh, C., Manjunath, G. B., Konai, M. M., Uppu, D. S. S. M., Hoque, J., Krishnamoorthy, P., Shome, B. R., & Haldar, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144094 · Cited by 44
Self-citationAtilano, M. L., Pereira, P. M., Vaz, F., Catalão, M. J., Reed, P., Grilo, I. R., Sobral, R. G., Ligoxygakis, P., Pinho, M. G., & Filipe, S. R. (2014) · eLife · doi:10.7554/elife.02277 · Cited by 43
Antiviral Screening of Multiple Compounds against Ebola Virus
Dowall, S., Bewley, K. R., Watson, R. J., Vasan, S. S., Ghosh, C., Konai, M. M., Gausdal, G., Lorens, J. B., Long, J. S., Barclay, W., et al. (2016) · Viruses · doi:10.3390/v8110277 · Cited by 43
Self-citationSully, E. K., Geller, B. L., Li, L., Moody, C. M., Bailey, S. M., Moore, A. L., Wong, M., Nordmann, P., Daly, S. M., Sturge, C. R., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw476 · Cited by 43
Uppu, D. S. S. M., Manjunath, G. B., Yarlagadda, V., Kaviyil, J. E., Ravikumar, R., Krishnamoorthy, P., Shome, B. R., & Haldar, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119422 · Cited by 39
Self-citationAryl-alkyl-lysines: Membrane-Active Small Molecules Active against Murine Model of Burn Infection
Ghosh, C., Manjunath, G. B., Konai, M. M., Uppu, D. S. S. M., Krishnamoorthy, P., Shome, B. R., Ravikumar, R., & Haldar, J. (2015) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00092 · Cited by 39
Self-citationAryl-alkyl-lysines: Membrane-Active Fungicides That Act against Biofilms of Candida albicans
Ghosh, C., Yadav, V., Younis, W., Mohammad, H. T., Hegazy, Y. A., Seleem, M. N., Sanyal, K., & Haldar, J. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6b00192 · Cited by 34
Self-citationGhosh, C., Sarkar, P., Samaddar, S., Uppu, D. S. S. M., & Haldar, J. (2017) · Chemical Communications · doi:10.1039/c7cc04206j · Cited by 33
Self-citationHoque, J., Konai, M. M., Samaddar, S., Gonuguntala, S., Manjunath, G. B., Ghosh, C., & Haldar, J. (2016) · Chemical Communications · doi:10.1039/c6cc90361d · Cited by 24
Self-citationDesigning Simple Lipidated Lysines: Bifurcation Imparts Selective Antibacterial Activity
Ghosh, C., Konai, M. M., Sarkar, P., Samaddar, S., & Haldar, J. (2016) · ChemMedChem · doi:10.1002/cmdc.201600400 · Cited by 23
Self-citationProgramming Bacteriophages by Swapping Their Specificity Determinants
Goren, M. G., Yosef, I., & Qimron, U. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.10.006 · Cited by 19
Cited by
Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects
Uddin, T. M., Chakraborty, A. J., Khusro, A., Zidan, B. R. M., Mitra, S., Emran, T. B., Dhama, K., Ripon, M. K. H., Gajdács, M., Sahibzada, M. U. K., et al. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.10.020 · Cited by 1,311
The global preclinical antibacterial pipeline
Theuretzbacher, U., Outterson, K., Engel, A., & Karlén, A. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0288-0 · Cited by 738
Antibiotic resistance genes from livestock waste: occurrence, dissemination, and treatment
He, Y., Yuan, Q., Mathieu, J., Stadler, L., Senehi, N., Sun, R., & Alvarez, P. J. J. (2020) · npj Clean Water · doi:10.1038/s41545-020-0051-0 · Cited by 588
Bacterial defences: mechanisms, evolution and antimicrobial resistance
Smith, W. P. J., Wucher, B. R., Nadell, C. D., & Foster, K. R. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00877-3 · Cited by 385
Mode-of-Action of Antimicrobial Peptides: Membrane Disruption vs. Intracellular Mechanisms
Benfield, A. H., & Henriques, S. T. (2020) · Frontiers in Medical Technology · doi:10.3389/fmedt.2020.610997 · Cited by 367
Metadata
- Authors
- Ghosh, C., Sarkar, P., Issa, R., & Haldar, J.
- Venue
- Trends in Microbiology
- Publisher
- Elsevier BV
- Published
- 2019-04
- Volume
- 27
- Issue
- 4
- Pages
- 323-338
- ISSN
- 0966-842X (ISSN-L)
- OpenAlex
- W2912354751
- Cited by
- 661
- References
- 116
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.